Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1081007

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1081007

Cell Culture Market (Product: Instruments, Media, Sera, and Reagents; and End-user: Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

PUBLISHED:
PAGES: 212 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

Cell Culture Market - Scope of Report

TMR's report on the global cell culture market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global cell culture market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cell culture market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cell culture market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cell culture market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global cell culture market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cell culture market.

The report delves into the competition landscape of the global cell culture market. Key players operating in the global cell culture market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cell culture market profiled in this report.

Key Questions Answered in Cell Culture Market Report

What will be the revenue generated in the cell culture market across all regions during the forecast period?

What are key trends in the cell culture market?

What are major drivers, restraints, and opportunities in the market?

Which region is set to expand at the maximum CAGR during the forecast period?

Which segment of the cell culture will generate the maximum revenue globally by 2028?

Which device segment will expand at the maximum CAGR during the forecast period?

Cell Culture Market - Research Objectives and Research Approach

The comprehensive report on the global cell culture market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cell culture market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cell culture market.

Product Code: TMRGL405

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cell Culture Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cell Culture Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Top 3 players operating in the market space
  • 5.2. Key Mergers & Acquisitions
  • 5.3. Technological Advancements
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Cell Culture Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 6.3.1. Instruments
      • 6.3.1.1. Cell Culture Vessels (bioreactor)
      • 6.3.1.2. Carbon Dioxide Incubators
      • 6.3.1.3. Biosafety Cabinets
      • 6.3.1.4. Cryogenic Tanks
      • 6.3.1.5. Others
    • 6.3.2. Media Type
      • 6.3.2.1. Chemically-defined
      • 6.3.2.2. Classical Media
      • 6.3.2.3. Lysogeny Broth (LB)
      • 6.3.2.4. Protein Free
      • 6.3.2.5. Serum Free
      • 6.3.2.6. Specialty Media
    • 6.3.3. Sera
      • 6.3.3.1. Fetal Bovine
      • 6.3.3.2. Newborn Calf
      • 6.3.3.3. Others
    • 6.3.4. Reagents
      • 6.3.4.1. Albumin
      • 6.3.4.2. Amino Acids
      • 6.3.4.3. Attached Factors
      • 6.3.4.4. Growth Factors & Cytokines
      • 6.3.4.5. Protease Inhibitors
      • 6.3.4.6. Thrombin
      • 6.3.4.7. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Cell Culture Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 7.3.1. Biotechnology & Pharmaceutical Companies
    • 7.3.2. Academic & Research Institutes
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Cell Culture Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value & Volume Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Cell Culture Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 9.2.1. Instruments
      • 9.2.1.1. Cell Culture Vessels (bioreactor)
      • 9.2.1.2. Carbon Dioxide Incubators
      • 9.2.1.3. Biosafety Cabinets
      • 9.2.1.4. Cryogenic Tanks
      • 9.2.1.5. Others
    • 9.2.2. Media Type
      • 9.2.2.1. Chemically-defined
      • 9.2.2.2. Classical Media
      • 9.2.2.3. Lysogeny Broth (LB)
      • 9.2.2.4. Protein Free
      • 9.2.2.5. Serum Free
      • 9.2.2.6. Specialty Media
    • 9.2.3. Sera
      • 9.2.3.1. Fetal Bovine
      • 9.2.3.2. Newborn Calf
      • 9.2.3.3. Others
    • 9.2.4. Reagents
      • 9.2.4.1. Albumin
      • 9.2.4.2. Amino Acids
      • 9.2.4.3. Attached Factors
      • 9.2.4.4. Growth Factors & Cytokines
      • 9.2.4.5. Protease Inhibitors
      • 9.2.4.6. Thrombin
      • 9.2.4.7. Others
  • 9.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 9.3.1. Biotechnology & Pharmaceutical Companies
    • 9.3.2. Academic & Research Institutes
    • 9.3.3. Others
  • 9.4. Market Value & Volume Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product Type
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Cell Culture Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 10.2.1. Instruments
      • 10.2.1.1. Cell Culture Vessels (Bioreactor)
      • 10.2.1.2. Carbon Dioxide Incubators
      • 10.2.1.3. Biosafety Cabinets
      • 10.2.1.4. Cryogenic Tanks
      • 10.2.1.5. Others
    • 10.2.2. Media Type
      • 10.2.2.1. Chemically-defined
      • 10.2.2.2. Classical Media
      • 10.2.2.3. Lysogeny Broth (LB)
      • 10.2.2.4. Protein Free
      • 10.2.2.5. Serum Free
      • 10.2.2.6. Specialty Media
    • 10.2.3. Sera
      • 10.2.3.1. Fetal Bovine
      • 10.2.3.2. Newborn Calf
      • 10.2.3.3. Others
    • 10.2.4. Reagents
      • 10.2.4.1. Albumin
      • 10.2.4.2. Amino Acids
      • 10.2.4.3. Attached Factors
      • 10.2.4.4. Growth Factors & Cytokines
      • 10.2.4.5. Protease Inhibitors
      • 10.2.4.6. Thrombin
      • 10.2.4.7. Others
  • 10.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 10.3.1. Biotechnology & Pharmaceutical Companies
    • 10.3.2. Academic & Research Institutes
    • 10.3.3. Others
  • 10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product Type
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Cell Culture Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 11.2.1. Instruments
      • 11.2.1.1. Cell Culture Vessels (bioreactor)
      • 11.2.1.2. Carbon Dioxide Incubators
      • 11.2.1.3. Biosafety Cabinets
      • 11.2.1.4. Cryogenic Tanks
      • 11.2.1.5. Others
    • 11.2.2. Media Type
      • 11.2.2.1. Chemically-defined
      • 11.2.2.2. Classical Media
      • 11.2.2.3. Lysogeny Broth (LB)
      • 11.2.2.4. Protein Free
      • 11.2.2.5. Serum Free
      • 11.2.2.6. Specialty Media
    • 11.2.3. Sera
      • 11.2.3.1. Fetal Bovine
      • 11.2.3.2. Newborn Calf
      • 11.2.3.3. Others
      • 11.2.3.4. Total
    • 11.2.4. Reagents
      • 11.2.4.1. Albumin
      • 11.2.4.2. Amino Acids
      • 11.2.4.3. Attached Factors
      • 11.2.4.4. Growth Factors & Cytokines
      • 11.2.4.5. Protease Inhibitors
      • 11.2.4.6. Thrombin
      • 11.2.4.7. Others
  • 11.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 11.3.1. Biotechnology & Pharmaceutical Companies
    • 11.3.2. Academic & Research Institutes
    • 11.3.3. Others
  • 11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product Type
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Cell Culture Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 12.2.1. Instruments
      • 12.2.1.1. Cell Culture Vessels (bioreactor)
      • 12.2.1.2. Carbon Dioxide Incubators
      • 12.2.1.3. Biosafety Cabinets
      • 12.2.1.4. Cryogenic Tanks
      • 12.2.1.5. Others
    • 12.2.2. Media Type
      • 12.2.2.1. Chemically-defined
      • 12.2.2.2. Classical Media
      • 12.2.2.3. Lysogeny Broth (LB)
      • 12.2.2.4. Protein Free
      • 12.2.2.5. Serum Free
      • 12.2.2.6. Specialty Media
    • 12.2.3. Sera
      • 12.2.3.1. Fetal Bovine
      • 12.2.3.2. Newborn Calf
      • 12.2.3.3. Others
    • 12.2.4. Reagents
      • 12.2.4.1. Albumin
      • 12.2.4.2. Amino Acids
      • 12.2.4.3. Attached Factors
      • 12.2.4.4. Growth Factors & Cytokines
      • 12.2.4.5. Protease Inhibitors
      • 12.2.4.6. Thrombin
      • 12.2.4.7. Others
  • 12.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 12.3.1. Biotechnology & Pharmaceutical Companies
    • 12.3.2. Academic & Research Institutes
    • 12.3.3. Others
  • 12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product Type
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Cell Culture Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 13.2.1. Instruments
      • 13.2.1.1. Cell Culture Vessels (bioreactor)
      • 13.2.1.2. Carbon Dioxide Incubators
      • 13.2.1.3. Biosafety Cabinets
      • 13.2.1.4. Cryogenic Tanks
      • 13.2.1.5. Others
    • 13.2.2. Media Type
      • 13.2.2.1. Chemically-defined
      • 13.2.2.2. Classical Media
      • 13.2.2.3. Lysogeny Broth (LB)
      • 13.2.2.4. Protein Free
      • 13.2.2.5. Serum Free
      • 13.2.2.6. Specialty Media
    • 13.2.3. Sera
      • 13.2.3.1. Fetal Bovine
      • 13.2.3.2. Newborn Calf
      • 13.2.3.3. Others
    • 13.2.4. Reagents
      • 13.2.4.1. Albumin
      • 13.2.4.2. Amino Acids
      • 13.2.4.3. Attached Factors
      • 13.2.4.4. Growth Factors & Cytokines
      • 13.2.4.5. Protease Inhibitors
      • 13.2.4.6. Thrombin
      • 13.2.4.7. Others
  • 13.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 13.3.1. Biotechnology & Pharmaceutical Companies
    • 13.3.2. Academic & Research Institutes
    • 13.3.3. Others
  • 13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product Type
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix
  • 14.2. Market Share Analysis, by Company, 2020
  • 14.3. Company Profiles
    • 14.3.1. Thermo Fisher Scientific, Inc.
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Strategic Overview
    • 14.3.2. Merck KGaA
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Strategic Overview
    • 14.3.3. Cytiva (Danaher Corporation)
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Strategic Overview
    • 14.3.4. Becton, Dickinson and Company
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Strategic Overview
    • 14.3.5. Corning Incorporated
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Strategic Overview
    • 14.3.6. Eppendorf SE
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Strategic Overview
    • 14.3.7. HiMedia Laboratories
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Strategic Overview
    • 14.3.8. Sartorius AG
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Strategic Overview
    • 14.3.9. FUJIFILM Irvine Scientific, Inc.
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Strategic Overview
    • 14.3.10. InvivoGen
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. SWOT Analysis
      • 14.3.10.4. Strategic Overview
    • 14.3.11. SeraCare (LGC Clinical Diagnostics, Inc.)
      • 14.3.11.1. Company Overview
      • 14.3.11.2. Product Portfolio
      • 14.3.11.3. SWOT Analysis
      • 14.3.11.4. Strategic Overview
    • 14.3.12. Miltenyi Biotec
      • 14.3.12.1. Company Overview
      • 14.3.12.2. Product Portfolio
      • 14.3.12.3. SWOT Analysis
      • 14.3.12.4. Strategic Overview
    • 14.3.13. STEMCELL Technologies, Inc.
      • 14.3.13.1. Company Overview
      • 14.3.13.2. Product Portfolio
      • 14.3.13.3. SWOT Analysis
      • 14.3.13.4. Strategic Overview
    • 14.3.14. Solida Biotech GmbH
      • 14.3.14.1. Company Overview
      • 14.3.14.2. Product Portfolio
      • 14.3.14.3. SWOT Analysis
      • 14.3.14.4. Strategic Overview
    • 14.3.15. Caisson Labs, Inc.
      • 14.3.15.1. Company Overview
      • 14.3.15.2. Product Portfolio
      • 14.3.15.3. SWOT Analysis
      • 14.3.15.4. Strategic Overview
    • 14.3.16. Cellexus
      • 14.3.16.1. Company Overview
      • 14.3.16.2. Product Portfolio
      • 14.3.16.3. SWOT Analysis
      • 14.3.16.4. Strategic Overview
    • 14.3.17. Pierre Guerin
      • 14.3.17.1. Company Overview
      • 14.3.17.2. Product Portfolio
      • 14.3.17.3. SWOT Analysis
      • 14.3.17.4. Strategic Overview

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cell Culture Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cell Culture Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Top 3 players operating in the market space
  • 5.2. Key Mergers & Acquisitions
  • 5.3. Technological Advancements
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Cell Culture Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 6.3.1. Instruments
      • 6.3.1.1. Cell Culture Vessels (bioreactor)
      • 6.3.1.2. Carbon Dioxide Incubators
      • 6.3.1.3. Biosafety Cabinets
      • 6.3.1.4. Cryogenic Tanks
      • 6.3.1.5. Others
    • 6.3.2. Media Type
      • 6.3.2.1. Chemically-defined
      • 6.3.2.2. Classical Media
      • 6.3.2.3. Lysogeny Broth (LB)
      • 6.3.2.4. Protein Free
      • 6.3.2.5. Serum Free
      • 6.3.2.6. Specialty Media
    • 6.3.3. Sera
      • 6.3.3.1. Fetal Bovine
      • 6.3.3.2. Newborn Calf
      • 6.3.3.3. Others
    • 6.3.4. Reagents
      • 6.3.4.1. Albumin
      • 6.3.4.2. Amino Acids
      • 6.3.4.3. Attached Factors
      • 6.3.4.4. Growth Factors & Cytokines
      • 6.3.4.5. Protease Inhibitors
      • 6.3.4.6. Thrombin
      • 6.3.4.7. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Cell Culture Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 7.3.1. Biotechnology & Pharmaceutical Companies
    • 7.3.2. Academic & Research Institutes
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Cell Culture Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value & Volume Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Cell Culture Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 9.2.1. Instruments
      • 9.2.1.1. Cell Culture Vessels (bioreactor)
      • 9.2.1.2. Carbon Dioxide Incubators
      • 9.2.1.3. Biosafety Cabinets
      • 9.2.1.4. Cryogenic Tanks
      • 9.2.1.5. Others
    • 9.2.2. Media Type
      • 9.2.2.1. Chemically-defined
      • 9.2.2.2. Classical Media
      • 9.2.2.3. Lysogeny Broth (LB)
      • 9.2.2.4. Protein Free
      • 9.2.2.5. Serum Free
      • 9.2.2.6. Specialty Media
    • 9.2.3. Sera
      • 9.2.3.1. Fetal Bovine
      • 9.2.3.2. Newborn Calf
      • 9.2.3.3. Others
    • 9.2.4. Reagents
      • 9.2.4.1. Albumin
      • 9.2.4.2. Amino Acids
      • 9.2.4.3. Attached Factors
      • 9.2.4.4. Growth Factors & Cytokines
      • 9.2.4.5. Protease Inhibitors
      • 9.2.4.6. Thrombin
      • 9.2.4.7. Others
  • 9.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 9.3.1. Biotechnology & Pharmaceutical Companies
    • 9.3.2. Academic & Research Institutes
    • 9.3.3. Others
  • 9.4. Market Value & Volume Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product Type
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Cell Culture Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 10.2.1. Instruments
      • 10.2.1.1. Cell Culture Vessels (Bioreactor)
      • 10.2.1.2. Carbon Dioxide Incubators
      • 10.2.1.3. Biosafety Cabinets
      • 10.2.1.4. Cryogenic Tanks
      • 10.2.1.5. Others
    • 10.2.2. Media Type
      • 10.2.2.1. Chemically-defined
      • 10.2.2.2. Classical Media
      • 10.2.2.3. Lysogeny Broth (LB)
      • 10.2.2.4. Protein Free
      • 10.2.2.5. Serum Free
      • 10.2.2.6. Specialty Media
    • 10.2.3. Sera
      • 10.2.3.1. Fetal Bovine
      • 10.2.3.2. Newborn Calf
      • 10.2.3.3. Others
    • 10.2.4. Reagents
      • 10.2.4.1. Albumin
      • 10.2.4.2. Amino Acids
      • 10.2.4.3. Attached Factors
      • 10.2.4.4. Growth Factors & Cytokines
      • 10.2.4.5. Protease Inhibitors
      • 10.2.4.6. Thrombin
      • 10.2.4.7. Others
  • 10.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 10.3.1. Biotechnology & Pharmaceutical Companies
    • 10.3.2. Academic & Research Institutes
    • 10.3.3. Others
  • 10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product Type
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Cell Culture Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 11.2.1. Instruments
      • 11.2.1.1. Cell Culture Vessels (bioreactor)
      • 11.2.1.2. Carbon Dioxide Incubators
      • 11.2.1.3. Biosafety Cabinets
      • 11.2.1.4. Cryogenic Tanks
      • 11.2.1.5. Others
    • 11.2.2. Media Type
      • 11.2.2.1. Chemically-defined
      • 11.2.2.2. Classical Media
      • 11.2.2.3. Lysogeny Broth (LB)
      • 11.2.2.4. Protein Free
      • 11.2.2.5. Serum Free
      • 11.2.2.6. Specialty Media
    • 11.2.3. Sera
      • 11.2.3.1. Fetal Bovine
      • 11.2.3.2. Newborn Calf
      • 11.2.3.3. Others
      • 11.2.3.4. Total
    • 11.2.4. Reagents
      • 11.2.4.1. Albumin
      • 11.2.4.2. Amino Acids
      • 11.2.4.3. Attached Factors
      • 11.2.4.4. Growth Factors & Cytokines
      • 11.2.4.5. Protease Inhibitors
      • 11.2.4.6. Thrombin
      • 11.2.4.7. Others
  • 11.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 11.3.1. Biotechnology & Pharmaceutical Companies
    • 11.3.2. Academic & Research Institutes
    • 11.3.3. Others
  • 11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product Type
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Cell Culture Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 12.2.1. Instruments
      • 12.2.1.1. Cell Culture Vessels (bioreactor)
      • 12.2.1.2. Carbon Dioxide Incubators
      • 12.2.1.3. Biosafety Cabinets
      • 12.2.1.4. Cryogenic Tanks
      • 12.2.1.5. Others
    • 12.2.2. Media Type
      • 12.2.2.1. Chemically-defined
      • 12.2.2.2. Classical Media
      • 12.2.2.3. Lysogeny Broth (LB)
      • 12.2.2.4. Protein Free
      • 12.2.2.5. Serum Free
      • 12.2.2.6. Specialty Media
    • 12.2.3. Sera
      • 12.2.3.1. Fetal Bovine
      • 12.2.3.2. Newborn Calf
      • 12.2.3.3. Others
    • 12.2.4. Reagents
      • 12.2.4.1. Albumin
      • 12.2.4.2. Amino Acids
      • 12.2.4.3. Attached Factors
      • 12.2.4.4. Growth Factors & Cytokines
      • 12.2.4.5. Protease Inhibitors
      • 12.2.4.6. Thrombin
      • 12.2.4.7. Others
  • 12.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 12.3.1. Biotechnology & Pharmaceutical Companies
    • 12.3.2. Academic & Research Institutes
    • 12.3.3. Others
  • 12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product Type
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Cell Culture Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value & Volume Forecast, by Product Type, 2017-2031
    • 13.2.1. Instruments
      • 13.2.1.1. Cell Culture Vessels (bioreactor)
      • 13.2.1.2. Carbon Dioxide Incubators
      • 13.2.1.3. Biosafety Cabinets
      • 13.2.1.4. Cryogenic Tanks
      • 13.2.1.5. Others
    • 13.2.2. Media Type
      • 13.2.2.1. Chemically-defined
      • 13.2.2.2. Classical Media
      • 13.2.2.3. Lysogeny Broth (LB)
      • 13.2.2.4. Protein Free
      • 13.2.2.5. Serum Free
      • 13.2.2.6. Specialty Media
    • 13.2.3. Sera
      • 13.2.3.1. Fetal Bovine
      • 13.2.3.2. Newborn Calf
      • 13.2.3.3. Others
    • 13.2.4. Reagents
      • 13.2.4.1. Albumin
      • 13.2.4.2. Amino Acids
      • 13.2.4.3. Attached Factors
      • 13.2.4.4. Growth Factors & Cytokines
      • 13.2.4.5. Protease Inhibitors
      • 13.2.4.6. Thrombin
      • 13.2.4.7. Others
  • 13.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 13.3.1. Biotechnology & Pharmaceutical Companies
    • 13.3.2. Academic & Research Institutes
    • 13.3.3. Others
  • 13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product Type
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix
  • 14.2. Market Share Analysis, by Company, 2020
  • 14.3. Company Profiles
    • 14.3.1. Thermo Fisher Scientific, Inc.
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Strategic Overview
    • 14.3.2. Merck KGaA
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Strategic Overview
    • 14.3.3. Cytiva (Danaher Corporation)
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Strategic Overview
    • 14.3.4. Becton, Dickinson and Company
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Strategic Overview
    • 14.3.5. Corning Incorporated
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Strategic Overview
    • 14.3.6. Eppendorf SE
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Strategic Overview
    • 14.3.7. HiMedia Laboratories
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Strategic Overview
    • 14.3.8. Sartorius AG
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Strategic Overview
    • 14.3.9. FUJIFILM Irvine Scientific, Inc.
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Strategic Overview
    • 14.3.10. InvivoGen
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. SWOT Analysis
      • 14.3.10.4. Strategic Overview
    • 14.3.11. SeraCare (LGC Clinical Diagnostics, Inc.)
      • 14.3.11.1. Company Overview
      • 14.3.11.2. Product Portfolio
      • 14.3.11.3. SWOT Analysis
      • 14.3.11.4. Strategic Overview
    • 14.3.12. Miltenyi Biotec
      • 14.3.12.1. Company Overview
      • 14.3.12.2. Product Portfolio
      • 14.3.12.3. SWOT Analysis
      • 14.3.12.4. Strategic Overview
    • 14.3.13. STEMCELL Technologies, Inc.
      • 14.3.13.1. Company Overview
      • 14.3.13.2. Product Portfolio
      • 14.3.13.3. SWOT Analysis
      • 14.3.13.4. Strategic Overview
    • 14.3.14. Solida Biotech GmbH
      • 14.3.14.1. Company Overview
      • 14.3.14.2. Product Portfolio
      • 14.3.14.3. SWOT Analysis
      • 14.3.14.4. Strategic Overview
    • 14.3.15. Caisson Labs, Inc.
      • 14.3.15.1. Company Overview
      • 14.3.15.2. Product Portfolio
      • 14.3.15.3. SWOT Analysis
      • 14.3.15.4. Strategic Overview
    • 14.3.16. Cellexus
      • 14.3.16.1. Company Overview
      • 14.3.16.2. Product Portfolio
      • 14.3.16.3. SWOT Analysis
      • 14.3.16.4. Strategic Overview
    • 14.3.17. Pierre Guerin
      • 14.3.17.1. Company Overview
      • 14.3.17.2. Product Portfolio
      • 14.3.17.3. SWOT Analysis
      • 14.3.17.4. Strategic Overview
Product Code: TMRGL405

List of Table

  • Table 01: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 03: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 04: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 05: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 06: Global Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 07: Global Cell Culture Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 08: North America Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 09: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 10: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 11: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 12: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 13: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 14: North America Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 17: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 18: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 19: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 20: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 21: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 22: Asia Pacific Cell Culture Market Value (US$ Mn) Analysis & Forecast, by Country/Sub-region, 2017-2031
  • Table 23: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 24: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 25: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 26: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 27: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 28: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 29: Latin America Cell Culture Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 30: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 31: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 32: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 33: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 34: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 35: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 36: Middle East & Africa Cell Culture Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 37: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 38: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 39: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 40: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 41: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 42: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Cell Culture Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Cell Culture Market Value Share, by Product, 2020
  • Figure 03: Global Cell Culture Market Value Share, End-user, 2020
  • Figure 04: Global Cell Culture Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 05: Global Cell Culture Market Revenue (US$ Mn), by Instruments, 2017-2031
  • Figure 06: Global Cell Culture Market Revenue (US$ Mn), by Media, 2017-2031
  • Figure 07: Global Cell Culture Market Revenue (US$ Mn), by Sera, 2017-2031
  • Figure 08: Global Cell Culture Market Revenue (US$ Mn), by Reagents, 2017-2031
  • Figure 09: Global Cell Culture Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 10: Global Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 11: Global Cell Culture Market Revenue (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2017-2031
  • Figure 12: Global Cell Culture Market Revenue (US$ Mn), by Academic and Research Institutes, 2017-2031
  • Figure 13: Global Cell Culture Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 14: Global Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 15: Global Cell Culture Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 16: Global Cell Culture Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 17: North America Cell Culture Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 18: North America Cell Culture Market Analysis Value Share Analysis, by Country, 2020 and 2031
  • Figure 19: North America Cell Culture Market Analysis Attractiveness Analysis, by Country 2021-2031
  • Figure 20: North America Cell Culture Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 21: North America Cell Culture Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 22: North America Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 23: North America Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 24: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 25: Europe Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 26: Europe Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 27: Europe Cell Culture Market Attractiveness Analysis, by Technique, 2021-2031
  • Figure 28: Europe Cell Culture Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 29: Europe Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 30: Europe Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 31: Asia Pacific Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017-2031
  • Figure 32: Asia Pacific Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 33: Asia Pacific Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 34: Asia Pacific Cell Culture Market Attractiveness Analysis, by Technique, 2021-2031
  • Figure 35: Asia Pacific Cell Culture Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 36: Asia Pacific Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 37: Asia Pacific Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 38: Latin America Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017-2031
  • Figure 39: Latin America Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 40: Latin America Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 41: Latin America Cell Culture Market Attractiveness Analysis, by Technique, 2021-2031
  • Figure 42: Latin America Cell Culture Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 43: Latin America Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 44: Latin America Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 45: Middle East & Africa Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017-2031
  • Figure 46: Middle East & Africa Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 47: Middle East & Africa Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 48: Middle East & Africa Cell Culture Market Attractiveness Analysis, by Technique, 2021-2031
  • Figure 49: Middle East & Africa Cell Culture Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 50: Middle East & Africa Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 51: Middle East & Africa Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!